international
Testing reveals popular weight loss peptide had double the strength on label
Key takeaways
- The testing showed the vial had double the concentration of what was listed on the label.
- Test results on an unapproved peptide have revealed double the concentration listed on the label, prompting warnings from health professionals about "enormous" overdose risks.
- The vial of black-market weight-loss peptide retatrutide was provided to the ABC for testing.
Why this matters: an international story with cross-border implications worth tracking.
The testing showed the vial had double the concentration of what was listed on the label. (Supplied)
Test results on an unapproved peptide have revealed double the concentration listed on the label, prompting warnings from health professionals about "enormous" overdose risks.
The vial of black-market weight-loss peptide retatrutide was provided to the ABC for testing.
Article preview — originally published by ABC Australia. Full story at the source.
Read full story on ABC Australia →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from ABC Australia alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop